SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 319.08 |
| Enterprise Value ($M) | 283.70 |
| Book Value ($M) | 40.56 |
| Book Value / Share | 0.16 |
| Price / Book | 7.87 |
| NCAV ($M) | 18.99 |
| NCAV / Share | 0.07 |
| Price / NCAV | 16.80 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.29 |
| Return on Assets (ROA) | -0.66 |
| Return on Equity (ROE) | -0.83 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.51 |
| Current Ratio | 2.51 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 42.97 |
| Assets | 64.55 |
| Liabilities | 23.98 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 6.04 |
| Operating Income | -65.53 |
| Net Income | -63.08 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -62.05 |
| Cash from Investing | 3.08 |
| Cash from Financing | 20.88 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 4.69 | 1.52 | |
| 13G/A | State Street Corp | 0.33 | -86.23 | |
| 13G/A | BlackRock Inc. | 1.50 | -74.06 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,129,843 | 6,631,466 | 32.12 | |
| 2,644,434 | 7,377,921 | 35.84 | |
| 1,955,673 | 1,166,660 | 167.63 | |
| 2,604,340 | 1,125,479 | 231.40 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NTBL – Notable Labs, Ltd. | NVCT – Nuvectis Pharma, Inc. |
| OCEA – Ocean Biomedical, Inc. | OCUP – Ocuphire Pharma, Inc. |
| OCX – OncoCyte Corporation |
Financial data and stock pages provided by
Fintel.io